Filing Flows › Revvity (RVTY) › Q3 2026
Revvity (RVTY) Q3 2026 earnings results (third quarter 2026)
8-K filed Nov 3, 2026
Revvity (RVTY) reported revenue of $729M for the third quarter 2026 (Q3 2026), +4% from a year earlier and -0.1% from the quarter before. Operating margin was 10.6%, net earnings $62.3M (8.5% of revenue).
Revvity, Q3 2026: revenue $729M (+4% year over year), operating margin 10.6%, net earnings $62.3M, operating cash flow $167M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $729M | -0.1% | +4% |
| Operating profit | $77.4M | -13% | -6% |
| Net earnings | $62.3M | +20% | +34% |
| Operating cash flow | $167M | -13% | +20% |
| Free cash flow | $152M | -16% | +27% |
What changed
Revenue was $728.9M in Q3 2026, up 4% year over year and roughly flat from the previous quarter. Life Sciences was the largest line at 52% of revenue. Life Sciences added $36.8M year over year (up 11%), 123% of the total change. Diagnostics declined 2%.
Operating profit was $77.4M, a 10.6% margin (down 1.1 points year over year). Operating profit fell $4.5M even though revenue rose $29.9M versus Q3 2025, so costs grew faster than sales. Total costs grew 6% against revenue growth of 4%. The fastest-growing cost line was SG&A (+14%). Net earnings were $62.3M, up 34% year over year. The effective tax rate was 19.5%.
Operating cash flow was $166.7M (up 20% year over year), 268% of net earnings. Non-cash charges added back $102.9M of depreciation and amortization and $9.8M of share-based compensation. Capital expenditures of $14.3M left free cash flow of $152.4M.
Questions
What was Revvity's revenue in the third quarter 2026?
Revvity (RVTY) reported revenue of $729M for the third quarter 2026 (Q3 2026), +4% from a year earlier and -0.1% from the quarter before.
Was Revvity profitable in the third quarter 2026?
Operating profit was $77.4M (10.6% of revenue) and net earnings $62.3M.
Source: Revvity 8-K on SEC EDGAR.